Ovarian Cancer Clinical Trial

Clinical Trial Finder Ovarian Cancer Trials

Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer

Summary

The purpose of this study is to learn more about the factors that influence decision-making before surgery (distress about cancer and/or reproductive concerns) and the possibility of regret after surgery.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Women aged â‰¥ 18 and â‰¤ 50 years
Premenopausal
Endometrioid histological diagnosis
Scheduled for surgical intervention at MSKCC
FIGO grade 1-2, clinical stage I
Disease confined to uterus, no clear evidence of deep (â‰¥50%) myoinvasion on imaging (MRI preferred, ultrasound optional)
Normal ovaries on preoperative imaging
Able to provide informed consent
English-speaking

Exclusion Criteria:

Known Lynch syndrome
Prior bilateral oophorectomy
Personal history of hormone receptor-positive breast carcinoma
Increased risk of ovarian cancer identified on the basis of family or personal history
Women currently on hormonal contraception, letrozole, or tamoxifen may not opt-in to AMH
Women who recently underwent ovarian stimulation within the past 3 months may not opt-in to AMH
Women who have pituitary dysfunction (or any pituitary disorders) may not opt-in to AMH
Women who completed chemotherapy within <12 months may not opt-in to AMH

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Hartford Healthcare (Data Collection)
Hartford Connecticut, 06102, United States More Info

Charles Rutter, MD
Contact
860-972-2803

Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge New Jersey, 07920, United States More Info